BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases
  • More
    • Home
    • About Us
    • Our Sciences
      • Cell-Derived Vesicle
      • BioDrone™ Platform
      • Manufacturing
      • Intellectual Properties
    • Pipeline
    • Publications
      • Publications
      • Posters & Presentations
    • Business
      • Business Model
      • Open Innovation
    • News
      • Press Releases
BioDrone Therapeutics Inc.
  • Home
  • About Us
  • Our Sciences
    • Cell-Derived Vesicle
    • BioDrone™ Platform
    • Manufacturing
    • Intellectual Properties
  • Pipeline
  • Publications
    • Publications
    • Posters & Presentations
  • Business
    • Business Model
    • Open Innovation
  • News
    • Press Releases

Intellectual Properties

MDimune has developed a robust IP portfolio to provide freedom to operate. Additional composition of matter claims will be able to be generated to protect collaborative programs. 


  • Over 50 patents are filed from 10+ patent families
  • 18+ patents are registered globally, including  those with the  US, EU, China, Japan, and Korea
  • Patents in 4 main categories - extrusion technology, therapeutic use, targeted delivery, and drug loading

Copyright © 2022 BioDrone Therapeutics Inc. - All Rights Reserved.

  • Contact